ArticleJAMA oncology2017

RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial.

Debora Fumagalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.